The original ZOE® Currently Available for Purchase with Physician’s Script

 

ZOE® Provides EARLY Identification of Decompensation, Prior to Symptom Development!
The ZOE® measures thoracic base impedence which is simply a measurement of the time it takes a small frequency electric current to travel from the top to the bottom of the thorax.

The more resistance the current meets, the drier or less fluid that exists. Conversely, the less resistance that the current meets, the wetter or more fluid that exists in the chest.

ZOE® measurement is a quick and easy method for determining whether individuals are experiencing fluid congestion or dehydration. Research indicates that Zo is an early predictor of congestion in heart failure, showing decreases as early as two weeks prior to weight gain and symptoms.

More Info on ZOE®

 


The ZOE® monitor is recommended for home or remote monitoring of:

  • Heart failure patients
  • Dialysis patients
  • Patients prone to dehydration or on increased dosage of diuretics

The ZOE® monitor is also recommended for first aid stations that need to screen and proactively treat dehydration at:

  • Sporting venues
  • Exercise clubs
  • Outdoor camps

-Download ZOE® Brochure

-Download ZOE® Case Study

-Managing Heart Failure in Home Care

-Download Clinical Comments

-Interview with Athens Home Health

-Comparison of Dissimilar Measurement Methodologies



Preferred Home Care Distributer of ZOE®

Company | Products | Patient Monitoring | Clinical Trials | Corporate Relations | Abstract/Case Studies | News | Contact
©2008, All Rights Reserved, NMT, Inc. | ETag™, IQ2™ and NcIQ™ are not yet FDA approved for sale